Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing
Status: | Recruiting |
---|---|
Conditions: | Cancer, Cancer, Other Indications |
Therapuetic Areas: | Oncology, Other |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 1/24/2018 |
Start Date: | October 1, 2017 |
End Date: | January 30, 2022 |
Contact: | Ana-Maria Vranceanu, PhD |
Email: | avranceanu@mgh.harvard.edu |
Phone: | 6176437996 |
The aims of this study are to compare the effect and durability of two stress and symptom
management programs tailored for patients with neurofibromatosis on quality of life and
psychosocial functioning.
management programs tailored for patients with neurofibromatosis on quality of life and
psychosocial functioning.
The aims of this study are to compare the effect of two stress and symptom management
programs tailored for patients with neurofibromatosis on quality of life and psychosocial
functioning. We will also examine the degree to which treatment-dependent improvements in
quality of life are mediated by improvements in depression, anxiety, distress, mindfulness,
gratitude, social support, empathy, optimism, coping, pain intensity and pain interference.
programs tailored for patients with neurofibromatosis on quality of life and psychosocial
functioning. We will also examine the degree to which treatment-dependent improvements in
quality of life are mediated by improvements in depression, anxiety, distress, mindfulness,
gratitude, social support, empathy, optimism, coping, pain intensity and pain interference.
Inclusion Criteria:
- Has a diagnosis of NF1, NF2, or Schwannomatosis
- 18 years of age or older
- Is capable of completing and fully understanding the informed consent process, study
procedures, and study assessments in English
- At least 6th grade self-reported reading level
- Self-reported difficulties coping with stress and NF-symptoms
- Score of 6 or higher on Perceived Stress Scale 4-Item (PSS-4)
Exclusion Criteria:
- Has major medical comorbidity not NF related expected to worsen in the next 12 months
- Recent (within past 3 months) change in antidepressant medication
- Recent (within past 3 months) participation in cognitive behavioral therapy or
relaxation therapy
- Has significant mental health diagnosis requiring immediate treatment (e.g., bipolar
disorder, psychotic disorder, active substance use dependence)
- Unable or unwilling to complete assessments electronically via REDCap
- Unable or unwilling to participate in group videoconferencing sessions
We found this trial at
1
site
185 Cambridge Street
Boston, Massachusetts 02114
Boston, Massachusetts 02114
617-724-5200
Phone: 617-643-7996
Click here to add this to my saved trials